Bsenexus Terminal Open in Bsenexus App →
BSE: 532497 RADICO NSE

RADICO KHAITAN LTD (532497) — Latest Corporate Announcements

₹4,535.1 ₹-19.90 (-0.44%)
Market Cap ₹60,765.38 Cr
P/E Ratio 86.33
52W Range ₹2500 – ₹4747
📅 Scheduled Board Meeting & Agenda
Meeting Date: 27-Oct-2026
Agenda / Purpose: Financial Results
Timeline: In 14 days
To consider and approve the financial results for the period ended September 30, 2026 Radico Khaitan Ltd - 532497 - Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026. Radico Khaitan Ltd - 532497 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Radico Khaitan Ltd - 532497 - Closure of Trading Window Radico Khaitan Ltd - 532497 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Radico Khaitan Ltd - 532497 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Radico Khaitan Ltd - 532497 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Radico Khaitan Ltd - 532497 - Announcement under Regulation 30 (LODR)-Newspaper Publication Radico Khaitan Ltd - 532497 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation To consider and approve the financial results for the period ended Jun 30, 2026 To consider and approve the financial results for the period ended March 31, 2026 and recommendation of dividend, if any. To consider and approve the financial results for the period ended December 31, 2025 To consider and approve the financial results for the period ended September 30, 2025 and other business matters To consider and approve the financial results for the period ended Jun 30, 2025 To consider and approve the audited Standalone and Consolidated financial results for the quarter and year ended March 31, 2025 and recommend dividend, if any To consider and approve the financial results for the period ended December 31, 2024 To consider and approve the financial results for the period ended September 30, 2024 To consider and approve the financial results for the period ended Jun 30, 2024 To consider and approve the financial results for the period ended March 31, 2024 and to recommend dividend, if any. To consider and approve the financial results for the quarter and nine months ended December 31, 2023
Quarter / Period Meeting / Outcome Date Status Filing Details
Quarter Ended 30-Sep-2026 (Q2 FY27) 27-Oct-2026 Scheduled Upcoming To consider and approve the financial results for the period ended September 30, 2026
Quarter Ended 30-Jun-2026 (Q1 FY27) 28-Jul-2026 Declared To consider and approve the financial results for the period ended Jun 30, 2026
Year Ended 31-Mar-2026 (Q4 FY26) 06-May-2026 Declared To consider and approve the financial results for the period ended March 31, 2026 and recommendation of dividend, if any.
Quarter Ended 31-Dec-2025 (Q3 FY26) 22-Jan-2026 Declared To consider and approve the financial results for the period ended December 31, 2025
Quarter Ended 30-Sep-2025 (Q2 FY26) 29-Oct-2025 Declared To consider and approve the financial results for the period ended September 30, 2025 and other business matters
Quarter Ended 30-Jun-2025 (Q1 FY26) 31-Jul-2025 Declared To consider and approve the financial results for the period ended Jun 30, 2025
Year Ended 31-Mar-2025 (Q4 FY25) (STD & CONSOL) 06-May-2025 Declared To consider and approve the audited Standalone and Consolidated financial results for the quarter and year ended March 31, 2025 and recommend dividend, if any
Quarter Ended 31-Dec-2024 (Q3 FY25) 29-Jan-2025 Declared To consider and approve the financial results for the period ended December 31, 2024
Quarter Ended 30-Sep-2024 (Q2 FY25) 24-Oct-2024 Declared To consider and approve the financial results for the period ended September 30, 2024
Quarter Ended 30-Jun-2024 (Q1 FY25) 07-Aug-2024 Declared To consider and approve the financial results for the period ended Jun 30, 2024
Year Ended 31-Mar-2024 (Q4 FY24) 14-May-2024 Declared To consider and approve the financial results for the period ended March 31, 2024 and to recommend dividend, if any.
Quarter Ended 31-Dec-2023 (Q3 FY24) 06-Feb-2024 Declared To consider and approve the financial results for the quarter and nine months ended December 31, 2023

What is the latest BSE announcement by RADICO KHAITAN LTD?

The latest BSE disclosure by RADICO KHAITAN LTD (RADICO), filed on 27-Oct-2026 , is: "To consider and approve the financial results for the period ended September 30, 2026". Bsenexus tracks every official filing for RADICO KHAITAN LTD with AI-powered summaries on its announcements feed.

When is RADICO KHAITAN LTD's next board meeting?

RADICO KHAITAN LTD has a board meeting scheduled for 27-Oct-2026 (in 14 days) to consider: Financial Results.

When does RADICO KHAITAN LTD declare quarterly results?

Under SEBI (LODR) Regulation 33, listed companies submit quarterly unaudited results within 45 days of the quarter ending, and annual audited figures within 60 days. RADICO KHAITAN LTD's recent results history is tabulated above. Track scheduled board meetings on the Bsenexus Results Calendar.